Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Longevity: Epitalon, MOTS-C
Not one pathway
Direct evidence for the exact combination is inadequate
Active cancer is a contraindication for most growth-factor-adjacent peptides because we do not want to fertilize a tumor we do not know about
BPC157 exhibits broad tissue repair capacity, suggesting that its actions may not depend on cell type-specific regulation (e.g., myocytes or epithelial cells) but rather target universal injury responses
Dimet-Wiley A, et al
US$ 28.77
US$ 28.98
US$ 29.20
US$ 27.84
US$ 26.77
